Trading Signals: CAPR Stock Price Prediction and Forecast (Tue. Apr. 1, 2003 - Fri. Jul. 2, 2021)(Capricor Therapeutics Inc)
| CAPR latest price $38.5700 (-2.11%) ($37.0000 - $38.5700) on Mon. May. 2, 2016. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 5.79% (three month average) | RSI | 78 | Latest Price | $38.5700(-2.11%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | CAPR declines -1.1% a day on average for past five trading days. | Weekly Trend | CAPR advances 10.2% a week on average for past two weeks. | Market Behavior | Broad based rally for large cap. Broad based rally for small cap. | Correlated ETFs | Broad market will support CAPR advance at 0% a week (0% probability) SKYY(8%) EWG(7%) EWI(7%) IVE(7%) PEJ(7%) | Factors Impacting CAPR price | CAPR will decline at least -2.895% in a week (0% probabilities). VIXM(-5%) TLT(-5%) SLV(-4%) GLD(-4%) GDX(-4%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -2.895% (StdDev 5.79%) | Hourly BBV | 0 () | Intraday Trend | 4.2% | | | |
|
5 Day Moving Average | $38.39(0.47%) | 10 Day Moving Average | $38.22(0.92%) | 20 Day Moving Average | $34.14(12.98%) | To recent high | -7.5% | To recent low | 83.7% | Market Cap | $760m | | | | Capricor Therapeutics, Inc. engages in the discovery, development and commercialization of first-in-class biological therapies for the treatment of cardiac and other serious medical conditions. Its product candidate consists of CAP-1002, Cenderitide, Exosomes, CAP-1001, CU-NP and CSps. The company was founded in August 2005 and is headquartered in Beverly Hills, CA. |